Medicare Enrolled
Dr. Shikha Rathi, MBBS, MD
Geriatric Medicine (Internal Medicine) Physician · Philadelphia, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rathi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rathi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rathi
Dr. Shikha Rathi is a geriatric medicine physician in Philadelphia, PA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Rathi performed 36,661 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rathi received a total of $14,766 from 49 pharmaceutical and/or device companies across 770 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rathi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 1% volume in PA
$14,766 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗36,661
Medicare services
Top 1% in PA for geriatric medicine (internal medicine) physician
Not available
Unique patients (not deduplicated)
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
10,600 | $11 | $30 |
| Romosozumab injection (Evenity) for osteoporosis | 7,770 | $8 | $12 |
| Denosumab injection (Prolia/Xgeva) | 6,540 | $18 | $30 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
6,067 | $26 | $135 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
4,250 | $34 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
338 | $102 | $150 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
247 | $107 | $500 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
183 | $11 | $125 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
115 | $7 | $120 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
111 | $24 | $200 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
97 | $59 | $156 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
75 | $72 | $125 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
68 | $129 | $225 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
64 | $4 | $30 |
| Injection, methylprednisolone acetate, 40 mg | 42 | $5 | $11 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
36 | $13 | $80 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
35 | $4 | $30 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
23 | $53 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
57.8% high complexity
40.9% medium
1.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,766
Total received (2018-2024)
Avg $2,109/year across 7 years
Top 5% in PA for geriatric medicine (internal medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
770
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,769
2023
$3,840
2022
$2,660
2021
$1,016
2020
$70
2019
$1,669
2018
$1,743
Payments by company (2024)
ABBVIE INC.
$504
UCB, Inc.
$456
Janssen Biotech, Inc.
$407
AstraZeneca Pharmaceuticals LP
$384
PFIZER INC.
$269
ANI Pharmaceuticals, Inc.
$243
Amgen Inc.
$210
Novartis Pharmaceuticals Corporation
$207
E.R. Squibb & Sons, L.L.C.
$206
Radius Health, Inc.
$144
Organon Llc
$126
GlaxoSmithKline, LLC.
$106
GENZYME CORPORATION
$96
Lilly USA, LLC
$62
Mallinckrodt Hospital Products Inc.
$57
Aurinia Pharma U.S., Inc.
$53
Genentech USA, Inc.
$35
Alexion Pharmaceuticals, Inc.
$31
Kyowa Kirin, Inc.
$28
TerSera Therapeutics LLC
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Sandoz Inc.
$25
Ultragenyx Pharmaceutical Inc.
$25
Kiniksa Pharmaceuticals International, plc
$22
Fresenius Kabi USA, LLC
$20
Top 3 companies account for 36.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,856
UCB, Inc.
$1,450
Janssen Biotech, Inc.
$1,362
PFIZER INC.
$1,337
ABBVIE INC.
$1,006
AstraZeneca Pharmaceuticals LP
$961
Novartis Pharmaceuticals Corporation
$887
ANI Pharmaceuticals, Inc.
$553
Genentech USA, Inc.
$523
E.R. Squibb & Sons, L.L.C.
$474
GlaxoSmithKline, LLC.
$412
AbbVie, Inc.
$339
Lilly USA, LLC
$325
Boehringer Ingelheim Pharmaceuticals, Inc.
$318
GENZYME CORPORATION
$309
Radius Health, Inc.
$305
Aurinia Pharma U.S., Inc.
$290
Exeltis, USA Inc.
$254
Mallinckrodt Hospital Products Inc.
$206
Flexion Therapeutics, Inc.
$201
Horizon Therapeutics plc
$170
Organon Llc
$126
Alexion Pharmaceuticals, Inc.
$93
Sobi, Inc
$90
Mylan Institutional Inc.
$80
Mallinckrodt Enterprises LLC
$79
MEDAC PHARMA, INC.
$68
AbbVie Inc.
$66
Sandoz Inc.
$60
DePuy Synthes Sales Inc.
$51
Mallinckrodt LLC
$49
Fresenius Kabi USA, LLC
$46
Kiniksa Pharmaceuticals, Ltd.
$40
Celgene Corporation
$39
MEDEXUS PHARMA, INC.
$38
Zimmer Biomet Holdings, Inc.
$37
Kyowa Kirin, Inc.
$28
TerSera Therapeutics LLC
$27
Merck Sharp & Dohme Corporation
$25
Pacira Pharmaceuticals Incorporated
$25
Ultragenyx Pharmaceutical Inc.
$25
Almatica Pharma LLC
$24
Kiniksa Pharmaceuticals International, plc
$22
Orthogenrx Inc.
$19
Ironwood Pharmaceuticals, Inc
$18
ASSERTIO THERAPEUTICS, Inc.
$15
SANOFI-AVENTIS U.S. LLC
$14
Hikma Pharmaceuticals USA
$14
Takeda Pharmaceuticals U.S.A., Inc.
$12
Top 3 companies account for 31.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUZALLO · EVENITY · EVUSHELD · Enbrel · GRALISE · Gel-One Cross-linked Hyaluronate · GenVisc 850 · HADLIMA · HUMIRA · HYRIMOZ · Hulio · Humira · IDACIO · ILARIS · INFLECTRA · Iovera · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OFEV · ORENCIA · ORTHOVISC · Otezla · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYNVISC-ONE · TALTZ · TAVNEOS · TREMFYA · Tymlos · Uloric · XELJANZ · Zilretta · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Geriatric medicine physicians in nearby ZIP areas
121
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
NAZARETH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rathi is a mixed practice specialist, with above-average Medicare volume (top 1% in PA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rathi experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Rathi performed 10,600 golimumab infusion (simponi aria) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rathi receive payments from pharmaceutical companies?
Yes. Dr. Rathi received a total of $14,766 from 49 companies across 770 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rathi's costs compare to other geriatric medicine physicians in Philadelphia?
Dr. Rathi's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rathi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Geriatric Medicine Physicians in Philadelphia
Browse geriatric medicine physicians in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Geriatric Medicine Physicians in PA
Geriatric medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Geriatric Medicine Physicians in PA
Which PA geriatric medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology